
Asia Pacific Blood Glucose Test Strip Market Analysis
Asia Pacific Blood Glucose Test Strip Market Research Report Information By Types (Glucose Oxidase, Glucose Dehydrogenase, other), Technology (Wicking Technology and Channel Technology), and End User (Hospital, Clinic, Household) -Forecast till 2035

Market Summary
The Asia-Pacific Blood Glucose Test Strip market is projected to grow from 2.14 USD billion in 2024 to 3.77 USD billion by 2035.
Key Market Trends & Highlights
Asia Pacific Blood Glucose Test Strip Key Trends and Highlights
- The market is expected to experience a compound annual growth rate of 5.29 percent from 2025 to 2035.
- By 2035, the market valuation is anticipated to reach 3.77 USD billion, indicating robust growth potential.
- In 2024, the market is valued at 2.14 USD billion, reflecting the increasing demand for diabetes management solutions.
- Growing adoption of advanced diabetes management technologies due to rising prevalence of diabetes is a major market driver.
Market Size & Forecast
2024 Market Size | 2.14 (USD Billion) |
2035 Market Size | 3.77 (USD Billion) |
CAGR (2025-2035) | 5.29% |
Largest Regional Market Share in 2024 | latin_america) |
Major Players
F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), B. Braun Melsungen Ag (Germany)
Market Trends
Asia Pacific Blood Glucose Test Strip Market Market Drivers
Market Segment Insights
Regional Insights
Key Companies in the Asia Pacific Blood Glucose Test Strip Market market include





Industry Developments
Market Segmentation
Report Scope
Attribute/Metric | Details |
Market Size 2023 | 2.03 (USD Billion) |
Market Size 2024 | 2.14 (USD Billion) |
Market Size 2032 | 3.17 (USD Billion) |
Compound Annual Growth Rate (CAGR) | 5.98 % (2024 - 2032) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year | 2023 |
Market Forecast Period | 2024 - 2032 |
Historical Data | 2019 - 2023 |
Geographies Covered | Asia Pacific |
Key Vendors | F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany). |
Key Market Opportunities | Increasing and glucose level monitoring is an important part of diagnosis and treatment of diabetes |
Key Market Drivers | Increasing healthcare expenditure and rising obese population have fuelled the growth of the market |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
-
BRIEF TOC
-
Report Prologue
-
Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
- Market Structure
- Market Segmentation
-
Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Market Size Estimation
- Forecast Model
-
Market Dynamics
- Drivers
- Restraints
- Opportunities
- Mega Trends
- Macroeconomic Indicators
-
Market Factor Analysis
- Value Chain Analysis
- Porter’s Five Forces
- Demand & Supply: Gap analysis
- Pricing Analysis
- Investment Opportunity Analysis
- Merger and Acquisition Landscape
-
UP-Coming trends in Asia Pacific Blood Glucose Test Strip Market
- Market trends
- Technological trends
-
Asia Pacific Blood Glucose Test Strip market by type
- Glucose Oxidase
- Glucose Dehydrogenase
- Other
-
Asia Pacific Blood Glucose Test Strip Market by technology
- Wicking technology
- Channel technology
-
Asia Pacific Blood Glucose Test Strip Market by End User
- Hospital
- Clinic
- Household
-
Asia Pacific Blood Glucose Test Strip Market by Region
- Introduction
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
-
10 Competitive Landscape
-
11 Company Profile
-
F. Hoffmann-La Roche Ltd
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
Abbott
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
LifeScan, Inc.
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Development
-
i-SENS. Inc.
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Development
-
AgaMatrix
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
TaiDoc Technology Corporation
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
BioSensors, Inc.
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
Universal Biosensors
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
-
Beijing Yicheng Electronic Co., Ltd
- Overview
- Product/Business Segment Overview
- Financial Updates
- Key Developments
- Others
-
F. Hoffmann-La Roche Ltd
-
12 Conclusion
-
Key Findings
- From CEO’s Viewpoint
- Unmet Needs of the Market
- Key Companies to Watch
- Prediction of Medical Devices Industry
-
Key Findings
-
13 Appendix
Asia Pacific Blood Glucose Test Strip Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment